Vanderbilt subsidiary, Standigm collaborate for AI drug discovery
Nashville Biosciences and Standigm are partnering to revolutionize early drug discovery using AI models created from de-identified genomic and clinical data.
Stay updated with breaking news from Treatment Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nashville Biosciences and Standigm are partnering to revolutionize early drug discovery using AI models created from de-identified genomic and clinical data.
Scientists create the first humanized mouse model for a rare genetic disease.
Image By: Robert M. Califf, M.D., Commissioner of Food and Drugs In 2021, a record number of Americans – more than 107,000 – died from drug overdoses. While the
Toronto, ON (PRWEB) November 01, 2021 -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical
Toronto, ON (PRWEB) November 01, 2021 -- Preclinical validation of an extended portfolio of prophylactic and therapeutic options against SARS-CoV-2-induced